Cutaneous malignant melanoma in Europe.

[1]  T. Holford,et al.  Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site , 1994, Cancer Causes & Control.

[2]  E. de Vries,et al.  Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe. , 2004, European journal of cancer.

[3]  Johan Moan,et al.  Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway) , 2004, Cancer Causes & Control.

[4]  J. Cuzick,et al.  Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK: a case-control study. , 2004, European journal of cancer.

[5]  A. Young.  Tanning devices--fast track to skin cancer? , 2004, Pigment cell research.

[6]  E. Holly,et al.  Incidence of cutaneous melanoma among non-Hispanic Whites, Hispanics, Asians, and Blacks: an analysis of California Cancer Registry data, 1988-93 , 1997, Cancer Causes & Control.

[7]  L. Dennis,et al.  Recent cohort trends in malignant melanoma by anatomic site in the United States , 1993, Cancer Causes & Control.

[8]  F Berrino,et al.  EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  O. Gefeller,et al.  Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study. , 2003, European journal of cancer.

[10]  F. Bray,et al.  Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia , 2003, International journal of cancer.

[11]  B L Diffey,et al.  A quantitative estimate of melanoma mortality from ultraviolet A sunbed use in the U.K. , 2003, The British journal of dermatology.

[12]  M. Ueda,et al.  UV-induced skin damage. , 2003, Toxicology.

[13]  K. Jöckel,et al.  Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. , 2003, Annals of epidemiology.

[14]  V. Bataille,et al.  Genetic epidemiology of melanoma. , 2003, European journal of cancer.

[15]  F. Watt,et al.  Contribution of stem cells and differentiated cells to epidermal tumours , 2003, Nature Reviews Cancer.

[16]  M. Tucker,et al.  Melanoma etiology: where are we? , 2003, Oncogene.

[17]  K. Czene,et al.  Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun‐exposed body sites , 2003, International journal of cancer.

[18]  G. Giglia-Mari,et al.  TP53 mutations in human skin cancers , 2003, Human mutation.

[19]  P. Carli,et al.  Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. , 2003, European journal of dermatology : EJD.

[20]  K. Czene,et al.  Familial and attributable risks in cutaneous melanoma: effects of proband and age. , 2003, The Journal of investigative dermatology.

[21]  H. Møller,et al.  Trends in the incidence of cutaneous malignant melanomas in the south east of England, 1960-1998. , 2002, Journal of public health medicine.

[22]  A. Ponsonby,et al.  Ultraviolet radiation and health: friend and foe , 2002, The Medical journal of Australia.

[23]  O. Gefeller,et al.  Vaccination and melanoma risk , 2002, International journal of cancer.

[24]  Annette Pfahlberg,et al.  Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. , 2002, The Journal of investigative dermatology.

[25]  M. Nicolson,et al.  Incidence of and survival from malignant melanoma in Scotland: an epidemiological study , 2002, The Lancet.

[26]  J. Lubin,et al.  Instrumental measurements of skin color and skin ultraviolet light sensitivity and risk of cutaneous malignant melanoma: a case-control study in an Italian population. , 2002, American journal of epidemiology.

[27]  B. Kulle,et al.  Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy. , 2002, European journal of cancer.

[28]  Bruce Kupelnick,et al.  Use of topical sunscreens and the risk of malignant melanoma: a meta-analysis of 9067 patients from 11 case-control studies. , 2002, American journal of public health.

[29]  Nop,et al.  Ozone layer - climate change interactions. Influence on UV levels and UV related effects , 2002 .

[30]  U. Ringborg,et al.  Trends in Incidence of Cutaneous Malignant Melanoma in a Swedish Population 1976-1994 , 2002, Acta oncologica.

[31]  K. Jöckel,et al.  Skin melanoma in Saarland: incidence, survival and mortality 1970–1996 , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[32]  C. la Vecchia,et al.  Trends in Skin Cancer Incidence in Neuchâtel, 1976-98 , 2001, Tumori.

[33]  C. Bellows,et al.  Melanoma in African‐Americans: Trends in biological behavior and clinical characteristics over two decades , 2001, Journal of surgical oncology.

[34]  D. Roberts,et al.  Malignant melanoma in South Wales: changing trends in presentation (1986–98) , 2001, Clinical and experimental dermatology.

[35]  C. la Vecchia,et al.  Trends in skin cancer incidence in Vaud: an update, 1976-1998. , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[36]  A. Jemal,et al.  Recent trends in cutaneous melanoma incidence among whites in the United States. , 2001, Journal of the National Cancer Institute.

[37]  A. Marghoob,et al.  Ultraviolet A and melanoma: a review. , 2001, Journal of the American Academy of Dermatology.

[38]  M. Holick,et al.  Sunlight “D”ilemma: risk of skin cancer or bone disease and muscle weakness , 2001, The Lancet.

[39]  A. Miller,et al.  An international evaluation of the cancer–preventive potential of sunscreens , 2000, International journal of cancer.

[40]  R. MacKie,et al.  Malignant melanoma: clinical variants and prognostic indicators , 2000, Clinical and experimental dermatology.

[41]  U. Ringborg,et al.  Trends in mortality from malignant melanoma in Sweden, 1970–1996 , 2000, Cancer.

[42]  J. Bulliard,et al.  Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. , 2000, International journal of epidemiology.

[43]  P. Boyle,et al.  Mortality from cutaneous melanoma: evidence for contrasting trends between populations , 2000, British Journal of Cancer.

[44]  A. Jemal,et al.  Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. , 2000, Journal of the National Cancer Institute.

[45]  H. Olsson,et al.  Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity , 2000, British Journal of Cancer.

[46]  S. Moss,et al.  Feasibility of targeted early detection for melanoma: a population-based screening study , 2000, British Journal of Cancer.

[47]  J. Bulliard.  Site‐specific risk of cutaneous malignant melanoma and pattern of Sun exposure in New Zealand , 2000, International journal of cancer.

[48]  D. Lipsker,et al.  Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. , 1999, Archives of dermatology.

[49]  L. Dennis.  Melanoma incidence by body site: effects of birth-cohort adjustment. , 1999, Archives of dermatology.

[50]  J. Naeyaert,et al.  The melanoma burden in Belgium; premature morbidity and mortality make melanoma a considerable health problem. , 1999, Melanoma research.

[51]  J. Naeyaert,et al.  Under-registration of melanoma in Belgium: an analysis. , 1999, Melanoma research.

[52]  J. Moan,et al.  Epidemiological Support for an Hypothesis for Melanoma Induction Indicating a Role for UVA Radiation , 1999, Photochemistry and photobiology.

[53]  B. Gilchrest,et al.  The pathogenesis of melanoma induced by ultraviolet radiation. , 1999, The New England journal of medicine.

[54]  C. la Vecchia,et al.  Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age , 1999, International journal of cancer.

[55]  Jacques Ferlay,et al.  Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.

[56]  L. Dennis,et al.  Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. , 1999, Archives of dermatology.

[57]  R. Gallagher,et al.  Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.

[58]  A. Rhodes,et al.  Cutaneous melanoma: patient surveillance and tumor progression. , 1998, Journal of the American Academy of Dermatology.

[59]  M. Weinstock,et al.  Do tanning lamps cause melanoma? An epidemiologic assessment. , 1998, Journal of the American Academy of Dermatology.

[60]  J. Melia,et al.  Why some cases of retinopathy worsen when diabetic control improves , 1997, BMJ.

[61]  P. Boyle,et al.  Should subjects who used psoralen suntan activators be screened for melanoma? Epidemiology and Prevention Subgroup, EORTC Melanoma Cooperative Group EORTC Prevention Research Division. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[62]  J. Coebergh,et al.  Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980 , 1997, The British journal of dermatology.

[63]  G. Bentham,et al.  Incidence of malignant melanoma of the skin in Norway, 1955-1989: associations with solar ultraviolet radiation, income and holidays abroad. , 1996, International journal of epidemiology.

[64]  F. Gruijl,et al.  Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements , 1996, Nature.

[65]  C. la Vecchia,et al.  Site distribution of different types of skin cancer: New aetiological clues , 1996, International journal of cancer.

[66]  G. Giles,et al.  Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994 , 1996, BMJ.

[67]  Geller,et al.  Melanoma and Skin Cancer Control: An International Perspective. , 1995, Cancer control : journal of the Moffitt Cancer Center.

[68]  G. P. Studzinski,et al.  Sunlight--can it prevent as well as cause cancer? , 1995, Cancer research.

[69]  J. Melia,et al.  Problems with registration of cutaneous malignant melanoma in England. , 1995, British Journal of Cancer.

[70]  R. Lew,et al.  The early detection of and screening for melanoma. International status , 1995, Cancer.

[71]  R. Halder,et al.  Skin cancer in African Americans , 1995, Cancer.

[72]  H. Olsson,et al.  Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. , 1994, American journal of epidemiology.

[73]  H. Adami,et al.  Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden. , 1994, British Journal of Cancer.

[74]  P. Autier,et al.  Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: An eortc multicenter case‐control study in Belgium, France and Germany , 1994 .

[75]  R. Burton,et al.  Recent incidence trends imply a nonmetastasizing form of invasive melanoma , 1994, Melanoma research.

[76]  B. Armstrong,et al.  How much melanoma is caused by sun exposure? , 1993, Melanoma research.

[77]  M. Pollán,et al.  Mortality trends in cutaneous malignant melanoma in Spain, 1967-1986. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[78]  H. G. Ainsleigh.  Beneficial effects of sun exposure on cancer mortality. , 1993, Preventive medicine.

[79]  R. Corona,et al.  Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991. , 1993, Annali dell'Istituto Superiore di Sanità.

[80]  C. Garbe,et al.  The German melanoma registry and environmental risk factors implied. , 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[81]  R. Lew,et al.  Underreporting of cutaneous melanoma in cancer registries nationwide. , 1992, Journal of the American Academy of Dermatology.

[82]  P. Sparén,et al.  Trends in mortality rates from malignant melanoma in Sweden 1953-1987 and forecasts up to 2007. , 1992, British Journal of Cancer.

[83]  T. Holford,et al.  A reversal in the long‐term increase in deaths attributable to malignant melanoma , 1992, Cancer.

[84]  A. Osterlind.  Epidemiology on malignant melanoma in Europe. , 1992, Acta oncologica.

[85]  J. Bulliard,et al.  Prevention of cutaneous melanoma: an epidemiological evaluation of the Swiss campaign. , 1992, Revue d'epidemiologie et de sante publique.

[86]  A. Verbeek,et al.  Trends in mortality from malignant cutaneous melanoma in The Netherlands, 1950-1988. , 1992, European journal of cancer.

[87]  J. Scotto,et al.  Indications of future decreasing trends in skin‐melanoma mortality among whites in the United States , 1991, International journal of cancer.

[88]  J. Nectoux,et al.  Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely , 1991, International journal of cancer.

[89]  U. Ringborg,et al.  Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984. , 1990, American journal of epidemiology.

[90]  D. Averbeck,et al.  Phototumorigenesis studies of 5-methoxypsoralen in bergamot oil: evaluation and modification of risk of human use in an albino mouse skin model. , 1990, Journal of Photochemistry and Photobiology. B: Biology.

[91]  H. J. V. D. Rhee,et al.  De 'sproetenbus'; een ongezond verschijnsel of een bezonnen experiment? , 1990 .

[92]  Donald R. Miller,et al.  Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. , 1990, Journal of the American Academy of Dermatology.

[93]  H. Williams,et al.  Evaluation of public education campaigns in cutaneous melanoma: the King's College Hospital experience , 1990, The British journal of dermatology.

[94]  C. Hertzman,et al.  The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. , 1990, American journal of epidemiology.

[95]  R. MacKie,et al.  PERSONAL RISK-FACTOR CHART FOR CUTANEOUS MELANOMA , 1989, The Lancet.

[96]  R. Philipp,et al.  Are malignant melanoma time trends explained by changes in histopathological criteria for classifying pigmented skin lesions? , 1988, Journal of epidemiology and community health.

[97]  T. Fitzpatrick.  The validity and practicality of sun-reactive skin types I through VI. , 1988, Archives of dermatology.

[98]  M. Maggini,et al.  Malignant melanoma mortality in Italy: 1955-1978. , 1984, European journal of cancer & clinical oncology.

[99]  B. Armstrong,et al.  A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. , 1983, Journal of the National Cancer Institute.

[100]  D. Skegg,et al.  Trends in malignant melanoma of skin in New Zealand , 1983, International journal of cancer.

[101]  K. Magnus.  Habits of sun exposure and risk of malignant melanoma: An analysis of incidence rates in Norway 1955–1977 by cohort, sex, age, and primary tumor site , 1981, Cancer.

[102]  B. Armstrong,et al.  Epidemiology of pre‐invasive and invasive malignant melanoma in Western Australia , 1980, International journal of cancer.

[103]  B. Cosman,et al.  THE INCREASING INCIDENCE OF MELANOMA , 1976, Plastic and reconstructive surgery.

[104]  K. Magnus.  Incidence of malignant melanoma of the skin in Norway, 1955–1970. Variations in time and space and solar radiation , 1973, Cancer.

[105]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[106]  J. A. Lee,et al.  Secular trends in mortality from malignant melanoma. , 1970, Journal of the National Cancer Institute.

[107]  Lancaster Ho,et al.  Some geographical aspects of the mortality from melanoma in Europeans. , 1956 .